Biosimilar User Fee Negotiations Under Way; Timetable Compressed

FDA has started biosimilar user fee negotiations with industry, although it does not appear the room is overcrowded with participants.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet